Home > Healthcare IT > Global Diabetic Retinopathy Market Size, Share, Trends, Global Growth & Forecast
Straits Research

Diabetic Retinopathy Market

Diabetic Retinopathy Market: Information By Type (Proliferative DR and Diabetic Macular Edema), Treatment Type (Anti VEGF Drug, Steroid Implants) and Regional Outlook—Forecast Till 2026

Table of Content Download Sample

Market Overview

The global diabetic retinopathy market accounted for over USD 6,810 million in 2017 and is expected to grow at a CAGR of 8.7% during the forecast period, 2019–2026

Diabetic retinopathy affects eyes and damages blood vessels of light-sensitive tissue at the back of the eye. According to the National Eye Institute, in 2014, approximately 7.7 million people suffered from diabetic retinopathy across the globe. Increasing prevalence of diabetic retinopathy across the globe is accelerating demand for diabetic retinopathy. According to the International Diabetes Federation (IDF), in 2015, approximately 415 million people suffered from diabetes globally, with 90% cases of type 2 diabetes representing 8.3% of the adult population. In addition, research & development initiatives, technological advancements, and improved healthcare facilities are expected to propel market growth. Changing lifestyle and increasing consumption of fast food are resulting in the high prevalence of obesity, which in turn is increasing the prevalence of diabetes.

Market Snapshot

market snapshot
Base Year
: 2017
Study Period
: 2016-2026
: 8.7 %
Fastest Growing Market
: North America
Largest Market
: Europe
Market Size
: USD 6,810 million in 2017
Get more information on this report Download Sample Report

Segmental Analysis

The global diabetic retinopathy market can be segmented by type and treatment type.

On the basis of type, the market can be segmented into proliferative diabetic retinopathy and diabetic macular edema (DME). The non-proliferative diabetic retinopathy (NPDR) segment is expected to hold a major market share, owing to high prevalence among patients within the bracket of less than 10 years of diabetic history.

Based on the treatment type, the market can be segmented into anti-VEGF drug, steroid implants, laser surgeries and vitrectomy. The anti-VEGF segment is expected to hold a major market share, owing to the high applicability of these drugs in the treatment of early diagnosis cases to facilitate rapid recovery.

Regional Analysis

Geographically, the global diabetic retinopathy market can be segmented into North America, Europe, Asia-pacific, and LAMEA.

North America is expected to hold a major market share due to the high prevalence of diabetes in the region. Obesity is a leading factor driving the prevalence of diabetes and in turn, growth of the diabetic retinopathy market. According to the Center for Disease Control and Prevention (CDC), in 2014, approximately 100 million among the U.S population had diabetes.

Europe is expected to hold a significant share of the diabetic retinopathy market, owing to the increasing prevalence of diabetes diseases, which in turn can be attributed to increasing environmental pollution and genetic disorders. According to the British Diabetic Association, in 2017, approximately 3.1 million people suffered from diabetes in the U.K. Apart from this, increasing government support to the diabetic patients by launching favorable reimbursement policies is also supporting market growth.

Asia Pacific is pegged to be the fastest growing market, due to the increasing prevalence of genetic diseases such as diabetics, and heart diseases. Additionally, government initiatives increasing awareness regarding diabetes are also expected to support market growth. For instance, government schemes such as Ayushman Bharat-National Health Protection Mission, and Indradhanus for chronic diseases are expected to drive market growth in India.

Latin America is expected to grow at a steady pace despite slow economic growth, backed by a growing healthcare sector.  The Middle East & Africa region holds the least market share due to poor healthcare infrastructure, and limited availability of funds in Africa.

Diabetic Retinopathy Market Regional Analysis
Regional Growth Insights Download Free Sample

Top Key Players of Diabetic Retinopathy Market

Some of the major players in the diabetic retinopathy market include 

  1. F. Hoffmann-La Roche Ltd.
  2. Novartis AG.
  3. Pfizer Inc.
  4. Bayer AG
  5. Isis Pharmaceuticals Inc.
  6. Valeant Pharmaceuticals Inc.
  7. Regeneron Pharmaceuticals Inc.
  8. Abbott Laboratories INC.
  9. Allergan Inc

Report Scope

Report Metric Details
CAGR 8.7%
Forecast Period 2023-2031
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered
  1. By Type
    1. Proliferative Diabetic Retinopathy
    2. Diabetic Macular Edema (DME)
  2. By Treatment Type
    1. Anti VEGF Drug
    2. Steroid Implants
    3. Laser Surgeries
    4. Vitrectomy
Geographies Covered
  • North America
  • Europe
  • APAC
  • Middle East and Africa

Diabetic Retinopathy Market Segmentation

By Type

  • Proliferative Diabetic Retinopathy
  • Diabetic Macular Edema (DME)

By Treatment Type

  • Anti VEGF Drug
  • Steroid Implants
  • Laser Surgeries
  • Vitrectomy

By Regional Covered

  • North America

    • U.S.
    • Canada
    • Mexico
  • Europe

    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific

    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific

    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
Price Starts From
USD 995

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Nippon Becton Dickinson
Argon Medical Devices
Johnson & Johnson
Need Assistance?
+1 646 480 7505 (U.S.)
+44 208 068 9665 (U.K.)

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Report Snapshot
Looking For Custom Report ?
Check Our License Options :

As featured on :

Trusted by Fortune 500
Over 30000+ subscribers